Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladan Fazli

Showing results (61-70 of 270) with videos related to

Pageof 27
Sort By:
Nature Communications|December 16, 2014
Clusterin facilitates stress-induced lipidation of LC3 and autophagosome biogenesis to enhance cancer cell survivalFan Zhang, Masafumi Kumano, Eliana Beraldi, et al.
The Prostate|May 27, 2010
Relaxin drives Wnt signaling through upregulation of PCDHY in prostate cancerVanessa C Thompson, Antonio Hurtado-Coll, Dmitry Turbin, et al.
Journal of the National Cancer Institute|September 8, 2005
A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2'-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancerKim N Chi, Elizabeth Eisenhauer, Ladan Fazli, et al.
NMR in Biomedicine|December 22, 2018
Comparing diagnostic accuracy of luminal water imaging with diffusion-weighted and dynamic contrast-enhanced MRI in prostate cancer: A quantitative MRI studyShirin Sabouri, Silvia D Chang, S Larry Goldenberg, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 29, 2017
MR measurement of luminal water in prostate gland: Quantitative correlation between MRI and histologyShirin Sabouri, Ladan Fazli, Silvia D Chang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 16, 2012
Targeting TCTP as a new therapeutic strategy in castration-resistant prostate cancerVirginie Baylot, Maria Katsogiannou, Claudia Andrieu, et al.
Molecular Cancer Therapeutics|October 1, 2014
The tyrphostin NT157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancerNaokazu Ibuki, Mazyar Ghaffari, Hadas Reuveni, et al.
The Prostate|February 19, 2010
Inhibition of DHCR24/seladin-1 impairs cellular homeostasis in prostate cancerMarie-Claude Battista, Marie-Odile Guimond, Claude Roberge, et al.
The Prostate|January 4, 2012
TP53INP1 as new therapeutic target in castration-resistant prostate cancerSophie Giusiano, Virginie Baylot, Claudia Andrieu, et al.
Molecular Cancer Research : MCR|October 13, 2023
RNF185 Control of COL3A1 Expression Limits Prostate Cancer Migration and Metastatic PotentialBenjamin Van Espen, Htoo Zarni Oo, Colin Collins, et al.
Pageof 27

Showing results (61-70 of 270) with videos related to

Sort By:
Pageof 27
Nature Communications|December 16, 2014
Clusterin facilitates stress-induced lipidation of LC3 and autophagosome biogenesis to enhance cancer cell survivalFan Zhang, Masafumi Kumano, Eliana Beraldi, et al.
The Prostate|May 27, 2010
Relaxin drives Wnt signaling through upregulation of PCDHY in prostate cancerVanessa C Thompson, Antonio Hurtado-Coll, Dmitry Turbin, et al.
Journal of the National Cancer Institute|September 8, 2005
A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2'-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancerKim N Chi, Elizabeth Eisenhauer, Ladan Fazli, et al.
NMR in Biomedicine|December 22, 2018
Comparing diagnostic accuracy of luminal water imaging with diffusion-weighted and dynamic contrast-enhanced MRI in prostate cancer: A quantitative MRI studyShirin Sabouri, Silvia D Chang, S Larry Goldenberg, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 29, 2017
MR measurement of luminal water in prostate gland: Quantitative correlation between MRI and histologyShirin Sabouri, Ladan Fazli, Silvia D Chang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 16, 2012
Targeting TCTP as a new therapeutic strategy in castration-resistant prostate cancerVirginie Baylot, Maria Katsogiannou, Claudia Andrieu, et al.
Molecular Cancer Therapeutics|October 1, 2014
The tyrphostin NT157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancerNaokazu Ibuki, Mazyar Ghaffari, Hadas Reuveni, et al.
The Prostate|February 19, 2010
Inhibition of DHCR24/seladin-1 impairs cellular homeostasis in prostate cancerMarie-Claude Battista, Marie-Odile Guimond, Claude Roberge, et al.
The Prostate|January 4, 2012
TP53INP1 as new therapeutic target in castration-resistant prostate cancerSophie Giusiano, Virginie Baylot, Claudia Andrieu, et al.
Molecular Cancer Research : MCR|October 13, 2023
RNF185 Control of COL3A1 Expression Limits Prostate Cancer Migration and Metastatic PotentialBenjamin Van Espen, Htoo Zarni Oo, Colin Collins, et al.
Pageof 27